TACLONEX Pages on BioPortfolio:

Biotechnology News TACLONEX Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/TACLONEX-news.htm...

BioPortfolio - Taclonex
Taclonex - BioPortfolio - Indepth. ... Companies working in the area of Taclonex from Bioportfolio's Biocorporate database : BioPortfolio Logo. Company Name ...
http://www.bioportfolio.com/indepth/Taclonex.html...

BioPortfolio's Approved Drugs News by Tradename - T to Th
... News updated every 20 minutes from thousands of internet sites. Click the link below to view the latest news: TAB-PROFEN · TACARYL · TACE · TACLONEX ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...

BioPortfolio News: LEO Pharma - LEO Pharma Officially Launches in ...
19 Jan 2010 ... TACLONEX (calcipotriene 0.005% and betamethasone dipropionate ... For full prescribing information for TACLONEX(R), visit www.taclonex.com. ...
http://www.bioportfolio.com/news/LEO-Pharma-Officially-Launc...

BioPortfolio's Approved Drugs News by Tradename - T to Th
Approved Drug Profile Alphabetical listing by Tradename - "T to Th" Click the link below to view profiles: TAB-PROFEN · TACARYL · TACE · TACLONEX ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_p...

BioPortfolio - Warner Chilcott
We strengthened and extended our position in the market for psoriasis therapies with the April 2006 launch of Taclonex® the first once-a-day topical ...
http://www.bioportfolio.com/biocorporate/10947-Warner+Chilco...

The Dermatology Market Outlook to 2013: Competitive landscape ...
... treatments is forecast to register strong growth between 2008-2013, driven by the performances of key drugs such as Raptiva, Taclonex, Soriatane. ...
http://www.bioportfolio.com/cgi-bin/acatalog/The-Dermatology...

BioPortfolio News: Warner Chilcott plc - Warner Chilcott Reports ...
Net sales of TACLONEX decreased $9.2 million, or 24.0%, to $29.0 million in the ... The decrease in TACLONEX net sales was primarily due to a contraction in ...
http://www.bioportfolio.com/news/Warner-Chilcott-Reports-Ope...

The World Dermatological Market Outlook 2010-2024
Taclonex • Dovonex • Propecia • Doryx • Surgicel Comprehensive analysis of the global dermatology market. The World Dermatological Market Outlook 2010-2024 ...
http://www.bioportfolio.com/cgi-bin/acatalog/The-World-Derma...

BioPortfolio Limited The World Dermatological Market Outlook 2010-2024
7.4.1 Sales Forecast for Taclonex, 2009-2024 7.5 Dovonex (Calcipotriol) .... Figure 7.7 Taclonex Sales Forecast ($m), 2009-2024 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_2230.html...

Results from other life science and pharmaceutical sites:

FDA Approvals: Climara Pro, Taclonex, Vivaglobin
The FDA has approved a new indication for an estradiol-levonorgestrel transdermal system, calcipotriene-betamethasone dipropionate 0.005%/0.064%
ointment, ...
http://www.medscape.com/viewarticle/521938...

DailyMed: About DailyMed
Taclonex Scalp® Topical Suspension is a vitamin D analog and .... Taclonex Scalp ® Topical Suspension contains calcipotriene that has been shown to be ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=14692...

FDA Approves Warner Chilcott's And LEO Pharma's Taclonex(R) - Once ...
LEO Pharma submitted the NDA for Taclonex® to the FDA in March 2005. Taclonex® is a topical ointment containing a combination of calcipotriene 0.005% and ...
http://www.biospace.com/news_story.aspx?NewsEntityId=6564...

TACLONEX (calcipotriene and betamethasone dipropionate) ointment ...
Each gram of Taclonex® Ointment contains 52.18 mcg of calcipotriene hydrate ( equivalent to 50 mcg of calcipotriene) and 0.643 mg of betamethasone ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=13853...

Taclonex (calcipotriene 0.005% and betamethasone dipropionate ...
Taclonex (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ointment. Abramovits W, Perlmutter A, Gupta AK. Baylor University Medical Center, ...
http://www.ncbi.nlm.nih.gov/pubmed/16687982...

Warner Chilcott And LEO Pharma Release: Taclonex(R) New Dual ...
3 Apr 2006 ... Warner Chilcott and LEO Pharma announced today that Taclonex® (calcipotriene 0.005% and betamethasone dipropionate 0.064%), a once-daily ...
http://www.biospace.com/news_story.aspx?NewsEntityId=14369...

...

Important Safety Information about Taclonex Scalpо Topical ...
Taclonex Scalpо is for the treatment of moderate to severe psoriasis ... You should not use Taclonex Scalpо if you have a history of allergy to any of its
...
http://www.wcrx.com/pdfs/TaclonexScalp.pdf...

Antipsoriatics - Pharmacy Clinical Policy Bulletins Aetna Medicare ...
Aetna considers Taclonex, Taclonex Scalp and Vectical to be medically ... Aetna considers Dovonex, Oxsoralen (lotion), Taclonex Scalp, Taclonex and Vectical ...
http://www.aetna.com/products/rxmedicare/data/Medicare2009/D...

Warner Chilcott
Taclonex® Ointment (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ... Taclonex Scalp® Topical Suspension (calcipotriene 0.005% and ...
http://www.wcrx.com/products_dermatology.jsp...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.